The Prevalence of HIV in Cancer Patients at the Surgical Oncology Unit of Donka University Hospital of Conakry (Guinea)

Traoré, B.; Bah, Thierno; Traore, Fodé Amara; Sow, Mamadou; Diane, Solomana; Keita, M.; Cissé, Mohamed; Koulibaly, M; Camara, Naby Daouda

doi:10.1155/2015/387896

Cited by 9 publications

(7 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among these, the most common was NHL, followed by cervical cancers. These ndings were similar to that reported by Venkatesh et al and Traore et al (11,25) . There were no reported cases of Kaposi's sarcoma in the present study.…”

Section: Discussionsupporting

confidence: 93%

“…However, the bene t of ART therapy did not reduced risk of development of Hodgkin's lymphoma and other non-AIDS de ning malignancies. 16 In the present series, majority of the patients (72%) had a non-AIDS de ning malignancies similar to the nding by Traore et al 25 . The cases in the present study included malignancies of the oral cavity, nasopharynx, larynx, female genital tract, haematolymphoid malignancies, lung, GIT including anal canal, breast carcinoma, male genital tract, eye, urinary tract and metastatic lesion with an unknown primary.…”

Section: Discussionsupporting

confidence: 87%

See 1 more Smart Citation

Emerging Patterns and Current Trends of AIDS Defining and Non-AIDS Defining Malignancies in HIV Infected Individuals from a Tertiary Care Center in South India

Philipose

Sundar

Ramapuram

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: People living with HIV/AIDS are at increased risk of developing malignancies- both AIDS defining and non-AIDS defining. The trends in incidence and severity of cancers among those with HIV/AIDS has greatly changed since the advent of ART. The aim of this study was to analyse the clinico-epidemiological profile of patients in South India with HIV/AIDS who subsequently developed malignancy. Methods: A retrospective study was conducted by reviewing the medical records of patients with HIV/AIDS who were diagnosed with cancer after seroconversion from January 2014 to December 2019 and presented to a tertiary medical centre. Results: Of the 627 cases of HIV presenting to the hospital during the study period, 50 (8%) developed cancer. Among the patients with cancer 14 (28%) had AIDS defining cancer while 36 (72%) had non- AIDS defining cancer. The mean CD4 cell count at the time of diagnosis with malignancy was 502.45/uL. Among the patients with AIDS defining malignancies, 10 patients (71.4%) had NHL, 3 patients (21.4%) had invasive cervical cancer and one patient (7.1%) was diagnosed with CNS lymphoma. Among the 36 cases of non-AIDS defining malignancies, there were 7 cases (19.4%) of malignancies of the upper airway (oral cavity, nasopharynx, larynx), 7 cases (19.4%) of malignancies of the female genital tract, 6 cases (16.7%) of haemato-lymphoid malignancies, 3 cases each (8.3%) of malignancies of the lung and GIT including anal canal. 2 cases each (5.6%) of breast carcinoma or carcinoma of the male genital tract. 1 case each (2.8%) of cancers of the eye, urinary tract and metastatic lesion with an unknown primary were also reported. Conclusion: Malignancies in HIV infected individuals in an emerging global health issue. In the present study, we report a prevalence of 8% of malignancies in HIV infected individuals and a higher incidence of non-AIDS defining malignancies.

show abstract

Section: Discussionsupporting

confidence: 93%

Section: Discussionsupporting

confidence: 87%

Emerging Patterns and Current Trends of AIDS Defining and Non-AIDS Defining Malignancies in HIV Infected Individuals from a Tertiary Care Center in South India

Philipose

Sundar

Ramapuram

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…This prevalence is in line with the study in KwaZulu-Natal, South Africa with the prevalence of 21% [ 9 ]. On the other hand, the result of this study is higher than the studies conducted in Ethiopia 13.3% [ 10 ], South Africa 7.2% [ 11 ], Nigeria 6%[ 12 ], Kenya 1.5% [ 13 ] and Guinea 2.1% [ 14 ]. This might be due to variations in the sample size, study period, study area and population.…”

Section: Discussioncontrasting

confidence: 78%

Human immune deficiency virus among cervical cancer patients at Tikur Anbessa Specialized Hospital, Ethiopia: a cross sectional study

2021

View full text Add to dashboard Cite

Background The discrepancy in cervical cancer incidence between women with HIV and women without HIV is highest in low and middle-income countries. In Africa, cervical cancer is the most common cause of cancer death. As a result, HIV-infected women are 6 times more likely to develop cervical cancer than uninfected women. In addition, HIV is associated with several triggering factors for cervical cancer, including multiple sexual partners, early sexual debut, economic status and substance use. Objective To assess the prevalence and associated factors of HIV among cervical cancer patients at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Methods A cross sectional study was conducted among 1057 cervical cancer patients registered from January 1, 2014 to December 31, 2018 at Oncology Center of Tikur Anbessa Specialized Hospital. A structured English version checklist was used to collect the data from patient charts. The pre coded data were entered in to EPI-data version 3.1 then exported to STATA version 14.0 for analysis. Both bivariable and multivariable regression analysis were carried out. Variables with p value < 0.05 in multivariable logistic regression were consider as significant predictors of the outcome variable. Result The prevalence of HIV among cervical cancer patients was 18.35%. HIV among cervical cancer patients was significantly associated with age group 30–39 [AOR = 2.83; 95%CI (1.27, 6.22)] and 40–49 [AOR = 2.39; 95%CI (1.07, 5.32)], employed [AOR = 2.23; 95%CI (1.46, 3.41)] and substance users [AOR = 3.92; 95%CI (2.04, 6.28)]. Conclusion This study revealed that about 18% of cervical cancer patients were HIV seropositive. HIV seropositivity was significantly increased with 30–49 age group, employed and substance users. Authors recommended that it is better to screen all HIV seropositive patients for cervical cancer and give greater attention for women with cervical cancer in the age groups of 30–49 years, employed and substance users.

show abstract

“…6 were reported HIV positive and out of this 6 cases reported only 5 had HIV+ Cancer .In our based study, we observed low proportion of HIV (0.28%) as well as HIV+ Cancer(0.23%) in cancer patients. Studies in this regards showed a high Proportion (2.1%) of the HIV infection in patients with cancer in surgical oncology unit ( 10,11 ). In a report from Maharashtra proportion of HIV was 1.2% (11 ).…”

Section: Discussionmentioning

confidence: 98%

Study of Proportion of HIV in Patients of Malignancy in Tertiary Care Cancer Hospital of Malwa Region of Punjab:A Hospital based Study

Arora¹,

Sandhu²,

Arora³

et al. 2020

IJPHRD

View full text Add to dashboard Cite

Introduction: Human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/ AIDS) is a spectrum of conditions caused by infection with the human immunodeficiency virus. The purpose of this study is to obtain data on the prevalence of HIV in the cancer population and vice versa at a major tertiary cancer in Bathinda and as the HIV population is also growing, the proportion, epidemiology and demographic profile of HIV in cancer patients need to be evaluated. Aims & Objectives:-To estimate the proportion of HIV infection among cancer patients visiting tertiary care hospital in District Bathinda and to study the demographic profile of patients suffering from HIV and cancer as primary outcome and to study the epidemiology of cancer among HIV-infected people as secondary outcome. Materials and Method:-Descriptive cross sectional study in cancer patients coming to tertiary care cancer hospital in Bathinda. Results & Conclusion:-In our hospital based study, we observed low proportion of HIV (0.28%) as well as HIV+ Cancer patients(0.23%). In cancer patients burden of HIV-infection will have implications for current and future cancer risk.

show abstract

The Prevalence of HIV in Cancer Patients at the Surgical Oncology Unit of Donka University Hospital of Conakry (Guinea)

Cited by 9 publications

References 16 publications

Emerging Patterns and Current Trends of AIDS Defining and Non-AIDS Defining Malignancies in HIV Infected Individuals from a Tertiary Care Center in South India

Emerging Patterns and Current Trends of AIDS Defining and Non-AIDS Defining Malignancies in HIV Infected Individuals from a Tertiary Care Center in South India

Human immune deficiency virus among cervical cancer patients at Tikur Anbessa Specialized Hospital, Ethiopia: a cross sectional study

Study of Proportion of HIV in Patients of Malignancy in Tertiary Care Cancer Hospital of Malwa Region of Punjab:A Hospital based Study

Contact Info

Product

Resources

About